logo
Select company
Select metric
13.33Current Ratio
VS
Market
95
Sector
90
Industry
85
History
100
$ 9.65Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 163.4M13.33$ 12.26M
3/31/2025$ 185.12M12.34$ 15M
12/31/2024$ 216.63M9.43$ 22.98M
9/30/2024$ 229.14M10.7$ 21.41M
6/30/2024$ 124.78M4.78$ 26.11M
3/31/2024$ 111.11M3.03$ 36.65M
12/31/2023$ 90.73M1.33$ 68.21M
9/30/2023$ 89.87M4.51$ 19.94M
6/30/2023$ 122.72M4.18$ 29.37M
3/31/2023$ 138.39M5.22$ 26.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 2.16.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Current Ratio has been 5.07.
  • The median Current Ratio for CARTESIAN THERAPEUTICS INC during this period was 4.34
  • CARTESIAN THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 13.33.
  • The lowest Current Ratio recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 1.33

CARTESIAN THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
HUMA : HUMACYTE INC 2.45NWBO : NORTHWEST BIOTHERAPEUTICS INC 0.07MREO : MEREO BIOPHARMA GROUP PLC 8.13INBX : INHIBRX BIOSCIENCES INC 4.98CRDF : CARDIFF ONCOLOGY INC 4.42BTAI : BIOXCEL THERAPEUTICS INC 0.76CATX : PERSPECTIVE THERAPEUTICS INC 15.09ADVM : ADVERUM BIOTECHNOLOGIES INC 1.54SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 0.26LSTA : LISATA THERAPEUTICS INC 5.77

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for CARTESIAN THERAPEUTICS INC is calculated as follows: AssetsC [ $ 166.5M ] / LiabilitesC [ $ 77M ]
(=) Current Ratio [ 2.16 ]

RNAC - Current Ratio, Last 5 years

1.33

Minimum

Dec 31, 2023

13.33

Maximum

Jun 30, 2025

5.07

Average

4.34

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44